In focus · trending topic

metastatic colorectal cancer

2 stories · following the connections

Cascadian Therapeutics Reports Third Quarter 2017 Financial Results

By Nasdaq OMXNov 8, 2017, 9:01 PM UTC

Cascadian Therapeutics Announces FDA Orphan Drug Designation Granted to Tucatinib for the Treatment of HER2+ Metastatic Colorectal Cancer

By Nasdaq OMXSep 27, 2017, 11:00 AM UTC